Madam Chair, I was speaking about the adverse reaction news letter and advisories which is a separate attachment to the Canadian Medical Association Journal . This increases its visibility and ensures distribution to the Canadian Medical Association's 64,000 members.
Health Canada has had a system for monitoring and assessing undesirable effects of drugs since 1965. With its vast experience in this field, the department is in an excellent position, in collaboration with all stakeholders, to improve post-market surveillance of all marketed health products, so that all Canadians will have access to important safety information.
I would also like to briefly discuss the issue of mandatory reporting. Department officials are conducting a review of the Canadian--